Glycans vs DNA: Why Biological Age Is Reversible

Your glycome, which is the full set of glycans (complex sugars) attached to your proteins and cells, is one of the most information-rich layers of human biology, integrating your genetic blueprint, epigenetic history, and lived environment into a single measurable signal. Unlike DNA, which is fixed at conception, glycans change in response to diet, stress, hormones, illness, and medical interventions, making them the most actionable biomarker available for tracking biological age.

For a deeper look at what glycans are and why they matter, see Glycans: The Sugars That Reveal Your Biological Age and Immune Health.

What are glycans, and how are they different from DNA?

Glycans are carbohydrate-based polymers present on virtually every cell surface in the body, attached to proteins and lipids through a tightly regulated process called glycosylation, and they are structurally far more complex than DNA. DNA is a linear sequence built from just four building blocks: adenine, guanine, cytosine, and thymine. Glycans, by contrast, can be branched structures assembled from a small set of sugar building blocks that combine in virtually limitless non-linear arrangements, making the glycome orders of magnitude more structurally diverse than the genome.

That structural complexity is not incidental. Glycans enable cell-to-cell communication, help proteins fold correctly, and regulate immune function. Your blood type, for example, is determined by which glycans are attached to your red blood cells. This detail illustrates how fundamental glycan biology is, even if the word itself is unfamiliar. The endothelial glycocalyx (the glycan-rich lining of your arteries) is another example: when it erodes, arterial health deteriorates measurably.

If my genes don't change, what's the point of testing them for longevity?

Genetic tests reveal risk, but risk you cannot change.

"Genetic risk is genetic risk. Whatever you do, you have the same genetic risk."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

Only 20–30% of complex diseases are actually genetic in origin, and many people carry mutations previously believed to be causative of disease without ever developing it. Prof. Lauc has noted that despite decades of investment, progress in genomics was never fully translated into tools that help people, partly because genetic risk alone tells you nothing about how to act on it.

Glycans fill that gap. They encode your original genetic risk plus what your lifestyle has done to your biology over the past decade. A DNA test is the starting line. GlycanAge tells you how far you've run, and in which direction.

How do glycans integrate genetics, epigenetics, and lifestyle into a single signal?

Glycan synthesis is controlled by a network of dozens to hundreds of genes, influenced simultaneously by epigenetic regulation and environmental factors, making glycans the only biomarker that reflects all three layers at once. When you look at a glycan profile, you are seeing genetic information, epigenetic information, and the downstream effects of diet, stress, hormones, and illness integrated into a single molecular readout.

This is what makes glycans structurally different from every other biomarker category. Standard blood markers (glucose, enzymes) fluctuate hour to hour and reflect acute physiology. Genes do not change at all. Glycans sit in between: stable enough to filter daily noise, responsive enough to capture meaningful biological change over weeks and months. Prof. Lauc describes them as "intermediate phenotypes between day-to-day altering molecules and genes which do not change", and predicts they will become "the most important prognostic biomarkers" in future medicine.

Why does GlycanAge respond to lifestyle interventions when DNA tests don't?

GlycanAge measures a functional, modifiable layer of biological age, not a fixed genetic blueprint. The glycan structures attached to Immunoglobulin G (IgG) antibodies shift in response to diet, exercise, pharmacotherapy, and hormonal change, and those shifts are measurable within months.

DNA tests cannot do this because the genome does not respond to what you eat or how you sleep. Glycans do, because glycosylation is a post-translational process, meaning it happens after the gene has been expressed, at the point where proteins are modified to become functional. That is the biological mechanism that makes the glycome modifiable and the genome static.

How is GlycanAge different from an epigenetic clock?

Epigenetic clocks measure patterns of gene regulation, which genes are being switched on or off, and reflect historical changes in how the genome has been expressed. Glycans are the functional effectors of that biology: they are what actually happens downstream.

Prof. Lauc draws a consistent distinction between the two: epigenetic data shows patterns of gene regulation, but the biological consequences of individual changes require extensive further study to interpret. Glycans operate at a different level, since they are functional effectors whose role in modulating immune response and inflammation is already well-characterised, with the biological meaning of each molecular change directly traceable in the literature.

Across large multi-omics studies comparing proteomics, metabolomics, glycomics, genomics, and epigenomics as ageing clocks, IgG glycans consistently rank among the strongest molecular correlates of biological age, and unlike epigenetic clocks, GlycanAge responds to lifestyle and medical interventions within 3–6 months.

Can I have a genetic predisposition to "bad" glycans?

Yes, but genetic predisposition is not genetic destiny when it comes to glycans. Because glycan synthesis is controlled by a network of dozens to hundreds of genes rather than a single gene, polymorphisms across that network can compensate for one another.

"By increasing expression of some of the genes in a network, we can compensate for a mutation somewhere else — or by changing our lifestyle and environmental factors, which also affect the glycome, we can change the final outcome."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

This is the practical implication: even if your baseline glycan profile reflects an unfavorable genetic starting point, the modifiable portion of that profile, driven by lifestyle, hormones, stress, and medical interventions, remains within your influence. Knowing your GlycanAge tells you where you are on that spectrum, and retesting tells you whether your interventions are moving it.

How quickly can glycans change, and what does that mean for tracking interventions?

Glycans are stable enough to distinguish real biological change from measurement noise, yet responsive enough to reflect meaningful shifts within months. This is the property that makes GlycanAge actionable in a way that DNA tests and epigenetic clocks are not. Prof. Lauc notes that in a difficult period, his own GlycanAge can accelerate, and that targeted lifestyle change reverses that trajectory.

The practical implication for longevity enthusiasts: GlycanAge is the measurement layer that closes the feedback loop. You can test a dietary change, a new training protocol, an HRT regimen, or a supplement stack, and retest in 3–6 months to see whether it has moved your inflammatory biology in the right direction. That is not possible with a DNA test, and the functional relevance of epigenetic clock readings remains an active area of scientific investigation.

I've already done a DNA test. What does GlycanAge add?

A DNA test tells you your genetic risk profile — fixed, unchanging, and silent on whether anything you are doing is working. GlycanAge measures the modifiable biology that sits downstream of your genes: the glycan structures on your IgG antibodies that reflect how chronic inflammation is driving your biological age right now. Where your genome encodes potential, your glycome encodes trajectory.

"Your usual early warning system is a heart attack, stroke, or diabetes diagnosis — and by then, most people are already beyond the point of no return. Once you have a chronic disease, it is very hard to completely eradicate it. But if you catch the signal early, when only the biomarkers are moving in that direction and there is still no tissue damage, everything is more or less fine — and you can fix it. Hopefully, you never develop that disease at all."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

For anyone who has already mapped their genetic risks, GlycanAge is the logical next step: the longitudinal measurement that gives those risk scores context and direction. If your DNA test flagged elevated cardiovascular risk, for example, one specific IgG glycan is among the best predictors of cardiovascular events, and tracking it over time tells you whether your interventions are reducing that risk at the molecular level. Genes tell you the hand you were dealt. GlycanAge tells you how you are playing it.

If you are ready to move beyond static genetic data and start measuring the biology that actually responds to what you do, order a GlycanAge test kit and receive a 1:1 Result Interpretation Call with a longevity specialist who will walk you through your biological age, your glycan indexes, and a personalised action plan.

Order your GlycanAge test → Shop now

External Sources

• https://pubmed.ncbi.nlm.nih.gov/24325898/ — Krištić J, Vučković F, Menni C, et al. "Glycans are a novel biomarker of chronological and biological ages." Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014; 69(7): 779–789.

• https://www.ncbi.nlm.nih.gov/books/NBK453052/ — Varki A, Cummings RD, Esko JD, et al., eds. "Cellular Organization of Glycosylation." In: Essentials of Glycobiology, 3rd edition. Cold Spring Harbor Laboratory Press; 2017.